ArticleFrontiers in medicine2026
The correlation between serum progesterone levels and syringoma.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Syringoma is a benign adnexal tumor that originates from the eccrine glands. Clinically, it manifests as multiple papules that range in size from 1 to 5 mm. These papules are typically skin-colored to yellowish and often appear in the periorbital region. Although not malignant, syringoma can be aesthetically disturbing and may affect an individual's self-confidence. The etiopathogenesis of syringoma is not fully understood, but the influence of progesterone has been suspected as a possible cause. Objective: This study aims to determine the correlation between serum progesterone levels and syringoma. Methods: This is an observational cross-sectional study involving 35 patients with syringoma and 35 patients without syringoma. Each patient underwent anamnesis, dermatologic and dermoscopic examinations, and blood sampling to assess serum progesterone levels using the enzyme-linked immunosorbent assay (ELISA) test. The data were analyzed using Fisher's exact test. Results: The majority of syringoma patients were found in the age range of 26-35 years, comprising 17 subjects (48.57%). The distribution of syringoma types showed that the most common was the localized form, found in 18 subjects (51.43%), followed by the familial form in 9 subjects (25.71%) and the generalized form in 8 subjects (22.86%). Analysis of serum progesterone levels indicated that among all study samples, 10 subjects (28.57%) with high progesterone levels belonged to the group syringoma, while only 2 subjects (5.71%) belonged to the control group. The results of this study demonstrate a positive correlation [OR 6.6 (95% CI 1.33-32.8), Conclusion: Syringoma predominantly affects young to mid-adult women, with localized forms most common and familial cases present. The lesions frequently occur in the periorbital region, particularly on the lower eyelid. A strong association between elevated progesterone levels and progesterone receptor expression suggests hormonal involvement. Progesterone may influence tumor development through its effects on sweat glands, keratinocytes, and skin structure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.